Andriol Testocaps Capsules 40mg

Country: Malasja

Lingwa: Ingliż

Sors: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ingredjent attiv:

TESTOSTERONE UNDECANOATE

Disponibbli minn:

MERCK SHARP & DOHME (MALAYSIA) SDN BHD

INN (Isem Internazzjonali):

TESTOSTERONE UNDECANOATE

Unitajiet fil-pakkett:

30Capsule Capsules; 120Capsule Capsules; 60Capsule Capsules

Manifatturat minn:

Catalent France Beinheim SA

Karatteristiċi tal-prodott

LPC -MK3033 -CP -072015 b 052017
ANDRIOL TESTOCAPS
Capsule
1. Name of the medicinal product
Andriol ® Testocaps ® 40 mg capsules 2. Qualitative and quantitative composition
Andriol Testocaps contain testoste rone undecanoate, a fatty acid ester of the natural
hormone testosterone. Each capsule contains 40 mg testosterone undecanoate
dissolved in a mixture of castor oil and propylene glycol laurate.
For excipients, see 6.1.
3. Pharmaceutical form
Capsules. Sof t oval glossy capsules, transparent, orange in colour, coded ORG DV3
containing a yellow oily fill.
4. Clinical particulars
4.1 Therapeutic indications
Testosterone replacement therapy in male s, for conditions associated with primary or
secondary hypogona dism (either congenital or acquired) when testosterone deficiency
has been confirmed by clinical features and biochemical tests .
4.2 Posology and method of administration
Posology
In general, the dose should be adjusted according to the response of the in dividual
patient.
Adult s
The initial dosage required will usually be 120 -160mg daily for 2 -3 weeks. Subsequent
dosage (40 -120mg daily) should be based on the clinical effect obtained during the first
weeks of therapy.
Elderly Patients